Cameroon vs Papua New Guinea: Hepatitis B surface antigen (HBsAg) prevalence
Cameroon
1.8%
in 2024
Papua New Guinea
2.5%
in 2024
Cameroon rank
13th
Papua New Guinea rank
10th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cameroon
- Papua New Guinea
How they compare
Papua New Guinea currently reports 2.5% against 1.8% in Cameroon, a difference of 0.7%.
That makes Papua New Guinea's figure about 1.4 times Cameroon's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Papua New Guinea ahead.
Cameroon ranks 13th and Papua New Guinea ranks 10th of 194 countries.
Across the 2 decades both report, Cameroon averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Cameroon | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 2.0% | 0.1% | Cameroon |
| 2020s | 2.0% | 2.4% | 0.5% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cameroon or Papua New Guinea?
- Papua New Guinea, at 2.5% against 1.8% in Cameroon as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cameroon and Papua New Guinea?
- 0.7%, with Papua New Guinea ahead.
- How many years of comparable data are there for Cameroon and Papua New Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cameroon and Papua New Guinea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cameroon ranks 13th and Papua New Guinea ranks 10th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.